Patents by Inventor Nadia Vezzio-Vie

Nadia Vezzio-Vie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-claudin 1 antibodies for use in the treatment of colorectal cancer
    Patent number: 9931416
    Abstract: The present invention relates to anti-claudin 1 antibodies for use in the treatment of colorectal cancer. In particular, the present invention relates to a method of treating a colorectal cancer in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an anti-claudin 1 (CLDN1) antibody.
    Type: Grant
    Filed: July 22, 2014
    Date of Patent: April 3, 2018
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), Universite de Montpellier, Institut Regional du Cancer de Montpellier
    Inventors: Marguerite Del Rio, Nadia Vezzio-Vie
  • Anti-Claudin 1 Antibodies and Uses Thereof
    Publication number: 20160185856
    Abstract: The present invention relates to anti-claudin 1 antibodies and their uses thereof. In particular, the present invention relates to an anti-Claudin 1 (CLDN1) antibody comprising n heavy chain variable region comprising SEQ ID NO:2 in the H-CDR1 region, SEQ ID NO:3 in the H-CDR2 region and SEQ ID NO:4 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO:6 in the L-CDR1 region, SEQ ID NO:7 in the L-CDR2 region and SEQ ID NO:8 in the L-CDR3 region.
    Type: Application
    Filed: July 22, 2014
    Publication date: June 30, 2016
    Applicants: INSERM(Institut National de la Sante et de la Recherche Medicale), Universite de Montpellier, Institut Regional du Cancer de Montpellier
    Inventors: Marguerite DEL RIO, Nadia VEZZIO-VIE
  • Anti-Claudin 1 Antibodies for Use in the Treatment of Colorectal Cancer
    Publication number: 20160158380
    Abstract: The present invention relates to anti-claudin 1 antibodies for use in the treatment of colorectal cancer. In particular, the present invention relates to a method of treating a colorectal cancer in a subject in need thereof comprising administering the subject with a therapeutically effective amount of an anti-claudin 1 (CLDN1) antibody.
    Type: Application
    Filed: July 22, 2014
    Publication date: June 9, 2016
    Inventors: Marguerite Del Rio, Nadia Vezzio-Vie